Cargando…
COVID-19-induced transaminitis and hyperbilirubinemia: Presentation and outcomes
The risk of liver injury in patients with coronavirus disease 2019 (COVID-19) infection is quite evident. Furthermore, liver function test abnormalities are still detected in COVID-19 patients despite the development of antivirals and the availability of several types of vaccines. This editorial des...
Autores principales: | Said, Zeinab Nabil Ahmed, El Habashy, Safinaz Adel, Zaky, Samy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011958/ https://www.ncbi.nlm.nih.gov/pubmed/36926664 http://dx.doi.org/10.3748/wjg.v29.i7.1123 |
Ejemplares similares
-
Hyperbilirubinemia without Transaminitis during Combined Therapy with Daclatasvir and Asunaprevir
por: Baba, Hayato, et al.
Publicado: (2016) -
Brucella melitensis-Induced Transaminitis
por: Essrani, Rajesh, et al.
Publicado: (2021) -
A Comprehensive Review of Transaminitis and Irritable Bowel Syndrome
por: Gadour, Eyad, et al.
Publicado: (2021) -
Acute Severe Transaminitis as a Unique Presentation of Chronic Cholecystitis
por: Fatima, Huda, et al.
Publicado: (2021) -
The Industrial Age of Biocatalytic Transamination
por: Fuchs, Michael, et al.
Publicado: (2015)